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ABSTRACT
Survival of the human malaria parasite Plasmodium falciparum is dependent on pantothenate (vitamin 
B5), a precursor of the fundamental enzyme cofactor coenzyme A. CJ-15,801, an enamide analogue of 
pantothenate isolated from the fungus Seimatosporium sp. CL28611, was previously shown to inhibit P. 
falciparum proliferation in vitro by targeting pantothenate utilization. To inform the design of next gen-
eration analogues, we set out to synthesize and test a series of synthetic enamide-bearing pantothenate 
analogues. We demonstrate that conservation of the R-pantoyl moiety and the trans-substituted double 
bond of CJ-15,801 is important for the selective, on-target antiplasmodial effect, while replacement of 
the carboxyl group is permitted, and, in one case, favored. Additionally, we show that the antiplasmodial 
potency of CJ-15,801 analogues that retain the R-pantoyl and trans-substituted enamide moieties corre-
lates with inhibition of P. falciparum pantothenate kinase (PfPanK)-catalyzed pantothenate phosphory-
lation, implicating the interaction with PfPanK as a key determinant of antiplasmodial activity. 
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1. Introduction 
Malaria is a widespread and lethal infectious disease trans-
mitted by the female Anopheles mosquito and caused by para-
sites of the genus Plasmodium. There are six species of Plas-
modium responsible for infections in humans [1,2]. Of these, 
P. falciparum is the most deadly [3] due to its ability to evade 
host defences during the blood stage of its development. 
Worldwide, there were an estimated 214 million new cases of 
malaria, with 438,000 deaths, in 2015 [3]. Children under the 
age of five years accounted for 306,000 of the deaths [3]. 
P. falciparum is reliant on exogenous pantothenic acid (1, 
Figure 1; also referred to as vitamin B5, and pantothenate, 
when ionized) a precursor of the ubiquitous enzyme cofactor 
coenzyme A (CoA). Analogues of pantothenate have been 
shown to compromise the parasite’s ability to utilize this vita-
min and thereby inhibit parasite proliferation [4-11], making 
them promising leads for new antimalarials. CJ-15,801 (R,E-
1a), an analogue of pantothenate containing a trans enamide 
unit, was isolated from the fermentation broth of the fungus 
Seimatosporium sp. CL28611 [12]. Following on from the 
initial observation that CJ-15,801 inhibits proliferation of 
Staphyloccocus aureus strains [12], CJ-15,801 was tested 
against blood stage P. falciparum parasites and shown to in-
hibit proliferation in vitro, with an IC50 value (the concentra-
tion yielding 50% inhibition) of 39 μM [9]. Importantly, the 
antiplasmodial effect is alleviated by increasing the concentra-
tion of pantothenate in the growth medium, consistent with the 
compound exerting an effect on parasite proliferation specifi-
cally by inhibiting pantothenate utilization or a process de-
pendent on pantothenate [9]. 
Figure 1. Pantothenic acid (1) and CJ-15,801 (R,E-1a). 
Owing to both the biological activity and interesting struc-
ture of CJ-15,801, this natural product has attracted significant 
interest. Correspondingly, a number of different approaches to 
the synthesis of CJ-15,801, with differing degrees of stereose-
lectivity, have been described [13-17]. 
Recent mechanistic investigations have revealed that in S. 
aureus CJ-15,801 is phosphorylated by pantothenate kinase 
(PanK), the enzyme that catalyzes the phosphorylation of pan-
tothenate in the first step of its transformation into CoA [18]. 
Subsequently, phospho-CJ-15,801 is accepted as a substrate 
by the next enzyme in the pathway (phosphopantothenoylcys-
teine synthetase, PPCS), and reacts to become cytidylylated. 
The cytidylylated phospho-CJ-15,801, which closely mimics 
the natural reaction intermediate and binds tightly and reversi-
bly to the enzyme, does not react further and instead inhibits 
the enzyme [18]. Whether a similar mechanism of action oper-
ates in P. falciparum remains to be determined. 
For the purpose of exploring the structural requirements for 
on-target antiplasmodial activity and probing the antiplasmo-
dial mechanism of action of CJ-15,801, we synthesized a se-
ries of novel enamide-bearing pantothenic acid analogues. 
Herein, we describe the synthesis of the new analogues, report 
on their effect on proliferation of P. falciparum and human 
cells, and in a PfPanK-catalyzed pantothenate phosphorylation 
assay. The study yielded a selective inhibitor of P. falciparum
proliferation with improved activity relative to CJ-15,801, and 
structure-activity relationship (SAR) information that can be 
used to inform design of a new generation of more potent an-
tiplasmodial pantothenate analogues. We also provide data 
consistent with PfPanK playing a role in the mechanism of 
action of these compounds. 
2. Results and discussion 
2.1 Chemistry 
To enable an exploration of the effect of double bond ge-
ometry, configuration about the chiral center, and carboxylate 
replacement on the antiplasmodial activity of CJ-15,801, com-
pounds 1a-e (Table 1) were synthesized. The effect of double 
bond substitution, and the importance of the “pantoyl” (2,4-
dihydroxy-3,3-dimethylbutyryl) moiety, were also explored 
(alone and in combination) through testing of enamides 1-2cMe
and 2-7c (Table 2). 
The synthesis of all enamides was achieved in high yield 
through olefination of the N-formyl imide precursors (pre-
pared from the corresponding amides) using previously de-
scribed methods (Schemes 1 – 3) [16,19]. The E/Z isomers 
were separated by flash column chromatography. CJ-15,801
and enamide analogues 1a-e and 1cMe (all of which possess a 
diol moiety) were synthesized from carboxamide 2g (Schemes 
Table 1. Antiplasmodial activity of CJ-15,801 analogues. 
                
Compound R 
                                      IC50 value against P. falciparum (μM)a
                         R               S 
trans cis trans cis 
1a OH 36 ± 4 (> 2.8)b > 200 > 100 > 100 
1b OMe > 200 > 200 > 100 > 100 
1c OEt 159 ± 12 (> 1.3) > 200 > 100 > 100 
1d OBn 13 ± 1 (> 7.7) 89 ± 11 (0.9 ± 0.1) > 100 > 100 
1e Ot-Bu 42 ± 5 (3.1 ± 0.4) 39 ± 2 (1.0 ± 0.1) > 100 > 100 
aIC50 values measured against P. falciparum parasites cultured (for 96 h) in medium containing 1 μM pantothenate are shown. The data 
are averages from 2 – 7 independent experiments, each performed in triplicate. IC50 values below the highest concentration tested are pre-
sented as the mean ± range/2 (n = 2) or SEM (n = 3 – 7). bValues in brackets show the fold-increase in IC50 value measured upon raising 
the pantothenate concentration from 1 to 100 μM. The fold-increase was calculated by dividing the IC50 value measured against P. falcipa-
rum parasites cultured (for 96 h) in medium containing 100 μM pantothenate by that measured in a paired experiment against parasites 
cultured in medium containing 1 μM pantothenate. The data are averages from two independent experiments, each performed in triplicate 
and errors represent range/2. 
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Table 2. Effect of double bond substitution and pantoyl 
replacement on the antiplasmodial activity of enamides. 
                              
Com-
pound 
R1 R2 IC50 value 
against 
P. falcipa-
rum (μM)a
(1 μM pan-
tothenate) 
Fold increase in 
IC50 with 100-
fold increase in 
pantothenateb
R,E-1c 
R,E-1cMe
H 
Me 
159 ± 12
> 200 
> 1.3 
ND 
R,E-2c 
R,E-2cMe
H 
Me 
144 ± 9 
93 ± 18 
0.9 ± 0.1 
1.0 ± 0.1 
E-3c
E-3cMe
H 
Me 
158 ± 25 
120 ± 18 
± 0.1 
1.0 ± 0.1 
E-4c H > 200 ND 
E-5c H 181 ± 15 0.9 ± 0.1 
E-6c H 93 ± 5 1.0 ± 0.1 
E-7c H 61 ± 6 1.4 ± 0.1 
aThe IC50 values measured against P. falciparum parasites cul-
tured (for 96 h) in medium containing 1 μM pantothenate, are 
shown. The data are averages from 2 – 4 independent experiments 
each performed in triplicate. IC50 values below the highest con-
centration tested are presented as the mean ± SEM (n = 3 or 4). 
bIn brackets is shown the fold-increase in IC50 value measured 
upon raising the pantothenate concentration from 1 to 100 μM. 
The fold-increase was calculated by dividing the IC50 value meas-
ured against P. falciparum parasites cultured (for 96 h) in medium 
containing 100 μM pantothenate by that measured in a paired 
experiment against parasites cultured in medium containing 1 μM 
pantothenate. The data are averages from two independent exper-
iments, each performed in triplicate and errors represent range/2. 
2 and 3). Treatment of the acetonide-bearing enamides with 
BiCl3 under previously described conditions [16] afforded the 
desired free diols (Scheme 2). CJ-15,801 and its stereoisomers
(all with carboxylic acid units) were synthesized via the trime-
thylsilyl (TMS) esters 2h (Scheme 3), a strategy that allowed 
the orthogonal deprotection of the carboxylic acid and diol 
units chemoselectively [16]. 
2.2 Antiplasmodial activity 
The effect of the enamide analogues of pantothenate on pro-
liferation of intraerythrocytic stage P. falciparum in vitro was 
assessed in 96 h proliferation assays. An IC50 value of 36 ± 4 
μM (mean ± SEM, n = 3) was determined for the chemically 
synthesized CJ-15,801 (Table 1), which matched that deter-
mined for CJ-15,801 isolated from the fungus Seimatosporium
(39 ± 3 μM) [9]. Methyl ester analogue R,E-1b, which was 
previously shown to lack inhibitory activity against S. aureus
[18], was also observed to be devoid of antiplasmodial activi-
ty. By contrast, however, ester analogues R,E-1c-e were found 
to inhibit proliferation of P. falciparum, consistent with the 
free carboxylic acid not being required for activity. The high-
est activity was observed for the benzyl ester analogue (R,E-
1d), which was approximately threefold more potent than CJ-
15,801 (IC50 = 13 ± 1 μM; mean ± SEM, n = 6). cis-CJ-15,801 
(R,Z-1a) and its ester analogues R,Z-1c-d were less active than 
their trans counterparts. 
None of the analogues with S-configuration at the chiral 
center of the pantoyl moiety (the opposite configuration of CJ-
15,801) were found to inhibit parasite proliferation with IC50
values below 100 μM, revealing a requirement for the natural 
R-configuration. For one ester analogue of CJ-15,801 (ethyl 
ester R,E-1c), the effect of substitution of the double bond and 
replacement of the pantoyl moiety was investigated (Table 2). 
While introduction of a methyl substituent and replacement of 
the pantoyl moiety with a pyridine ring were not tolerated 
(IC50  200 μM), replacement of the pantoyl moiety with a 
ketal group, phenyl ring, or incorporation of the amide group 
into a lactam ring, was, and in a few cases, an increase in an-
tiplasmodial activity was observed (e.g. lactam E-7c). 
Scheme 1. General synthesis of enamides from amides. 
Reagents and conditions: (i) n-BuLi, THF, 0 °C, 0.5 h then N-
formylbenzotriazole, THF, 0 ºC, 50 – 81%; (ii) C6H6, 80 °C, 18 h, 
37 – 98%.
Scheme 2. Synthesis of CJ-15,801 analogues 1b-e and 1cMe.  
Reagents and conditions: (i) C6H6, 80 °C, 18 h, 87 – 98%; 
(ii) BiCl3, aq. MeCN, RT, 3 – 18 h, 29 – 71%. 
Scheme 3. Synthesis of CJ-15,801 and isomers with a car-
boxylic acid. 
Reagents and conditions: (i) C6H6, 80 °C, 18 h, 96%; (ii) TBAF 
(1M in THF), THF, 0 °C, 20 h, 84% (trans), 92% (cis); (iii) BiCl3, 
aq. MeCN, RT, 3 – 18 h, 63% (trans), 26% (cis). 
When the concentration of pantothenate in the growth me-
dium was increased 100-fold, the effect of CJ-15,801 was 
alleviated (Figure 2A). This result, which parallels a previous 
observation made with CJ-15,801 isolated from the fungus 
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that produces it [9], is consistent with the compound exerting 
an antiplasmodial effect through inhibition of CoA biosynthe-
sis and/or utilization. We therefore set out to investigate the 
effect of increasing the pantothenate concentration on the an-
tiplasmodial activity of the additional enamide analogues for 
which IC50 values had been determined. 
Figure 2. Effect of pantothenate supplementation on the an-
tiplasmodial activity of CJ-15,801 (A) and enamides R,E-1c (B), 
R,E-1d (C) and R,E-1e (D). The effect of increasing concentra-
tions of the enamides on proliferation of P. falciparum parasites 
cultured (for 96 h) in medium containing 1 μM (closed circles) or 
100 μM (open circles) pantothenate is shown. The data obtained 
with parasites cultured in 1 μM pantothenate are from 3 – 8 inde-
pendent experiments each performed in triplicate. The data ob-
tained with parasites cultured in the presence of 100 μM panto-
thenate are from 2 – 4 independent experiments each performed in 
triplicate. Error bars represent range/2 or SEM, and where not 
shown, are smaller than the symbol. 
As shown in Figure 2B-D, increasing the pantothenate con-
centration 100-fold resulted in attenuation of the antiplasmo-
dial activity of compounds R,E-1c-e – all enamides with both 
a pantoyl moiety with R-configuration and a trans-substituted 
double bond (analogous to CJ-15,801). This is consistent with 
these compounds also acting through inhibition of CoA bio-
synthesis and/or utilization. The attenuating effect of panto-
thenate was greatest for the more active of these compounds 
(CJ-15,801, R,E-1d and R,E-1e). This is likely to be because 
the lower concentrations of these analogues required for an on- 
target antiplasmodial effect are farther from concentrations
with a non-specific toxic effect, as compared with the less 
active R,E-1c. Interestingly, increasing the pantothenate con-
centration 100-fold does not attenuate the activity of R,Z-1d-e 
(the active R-pantoyl enamides with a cis-substituted double 
bond; Table 1), consistent with these compounds, by contrast, 
acting via a different mechanism. Similarly, increasing the 
pantothenate concentration has no effect on the activity of the 
active enamides without the pantoyl moiety (Table 2), except 
for E-7c, for which a small (1.4-fold) increase in IC50 was 
observed. This finding implicates both the R-pantoyl moiety 
and trans-substituted double bond as being required for a CoA 
biosynthesis/utilization-related antiplasmodial effect. 
2.3 Inhibition of pantothenate phosphorylation 
Previously it was shown that CJ-15,801 inhibits the accu-
mulation of pantothenate (a combination of transport and sub-
sequent trapping by phosphorylation) within P. falciparum
parasites [9]. Here we investigated directly whether this was a 
consequence of inhibition of pantothenate phosphorylation by 
measuring phosphorylation of pantothenate by PanK in P. 
falciparum lysate in the presence of CJ-15,801. When tested at 
100 μM, CJ-15,801 was observed to inhibit pantothenate 
phosphorylation by 87 ± 1% (mean ± SEM, n = 3, Figure 3). 
Of the additional enamides with a free diol moiety (1a-e and 
1cMe), all those with both R-configuration and a trans-
substituted double bond also inhibited pantothenate phosphor-
ylation (including those without an effect on parasite prolifera-
tion at the same concentration). Ester analogues R,E-1b-e
showed the greatest effect, inhibiting phosphorylation of pan-
tothenate by > 90% at 100 μM. The effect of the same concen-
tration of the corresponding enamides with a free diol moiety 
with S-configuration and/or a cis-substituted double bond 
(R,Z-, S,E-, or S,Z-1a-e) was notably less (Figure 3); with a 
few exceptions (S,E-1b, R,Z-1c, and R,Z-, S,E-, and S,Z-1d) < 
25% inhibition was observed. The results suggest that alt-
hough some enamides with a S-pantoyl moiety and/or a cis-
substituted double bond are able to interact with PfPanK, R-
configuration and a trans-substituted enamide moiety is re-
quired for more potent inhibition of pantothenate phosphoryla-
tion. The enamides that do not retain the free diol moiety gen-
erally had little-to- no-effect on pantothenate phosphorylation 
(Supporting information Figure S1). 
IC50 values for inhibition of pantothenate phosphorylation 
were determined for the enamides with a free pantoyl moiety 
with R-configuration and a trans-substituted double bond 
Figure 3. Effect of enamide analogues of pantothenate on 
PfPanK-catalyzed pantothenate phosphorylation. [14C]Pantothe-
nate phosphorylation by PanK in P. falciparum lysate was meas-
ured in the presence of 100 μM of each enamide. The concentra-
tion of pantothenate present in the assay was 1.8 μM (R-
compounds, A) or 1 μM (S-compounds, B). The percentage inhi-
bition was calculated from the measured amounts of 
[14C]pantothenate phosphorylated during a pre-determined incu-
bation period (in which phosphorylation increased linearly with 
time in the absence of inhibitors) in the presence of enamide or 
the corresponding concentration of DMSO only. The data are 
from 3 – 8 independent experiments, each performed in duplicate. 
Error bars represent SEM. A dash in place of a column indicates 
that the compound was not tested in the assay.
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Figure 4. Concentration-dependent effect of enamides with a R-
pantoyl moiety and trans-substituted double bond on PfPanK-
catalyzed pantothenate phosphorylation. [14C]Pantothenate phos-
phorylation by PanK in P. falciparum lysate was measured in the 
presence of 1.8 μM pantothenate. The percentage inhibition was 
calculated from the measured amounts of [14C]pantothenate phos-
phorylated during a 15 min incubation (in which phosphorylation 
increased linearly with time in the absence of inhibitors) in the 
presence or absence of increasing concentrations of each enamide. 
The data are from 2 – 5 independent experiments, each performed 
in duplicate. Error bars represent range/2 or SEM, and where not 
shown, are smaller than the symbol. 
(Figure 4). The ester analogues of CJ-15,801 (R,E-1b-e) were 
all found to inhibit pantothenate phosphorylation more effec-
tively than CJ-15,801, with the most effective inhibitor – ben-
zyl ester R,E-1d – inhibiting pantothenate phosphorylation 
with an IC50 value of 140 ± 40 nM (mean ± SEM, n = 5), 100-
fold lower than that of CJ-15,801 (IC50 = 14 ± 3 μM, mean ± 
SEM, n = 3; Figure 4). Introduction of a methyl substituent to 
the double bond (as in compound 1cMe) was observed to re-
duce inhibitory activity. Notably, for these ester analogues of 
CJ-15,801, the same trend was observed for inhibitory activity 
against pantothenate phosphorylation as for antiplasmodial 
activity (benzyl ester R,E-1d > tert-butyl ester R,E-1e > ethyl 
ester R,E-1c > methyl ester R,E-1b, and ethyl ester with me-
thyl substituent R,E-1cMe). CJ-15,801, however, notably does 
not fit this trend – showing only a modest effect on pantothe-
nate phosphorylation despite being among the best inhibitors 
of parasite proliferation. 
The enamide analogues of pantothenate may inhibit panto-
thenate phosphorylation by one of two mechanisms: (i) by 
directly inhibiting PfPanK, or (ii) by serving as alternate sub-
strates that are competitively phosphorylated. It is noteworthy 
that the IC50 value of the best pantothenate phosphorylation 
inhibitor is 13-fold lower than the pantothenate concentration 
present in the assay (1.8 μM). Assuming competition for the 
same binding site, this is consistent with the enamide binding 
PanK with higher affinity and/or being turned over more slow-
ly than the natural substrate. CJ-15,801 has been shown to be 
phosphorylated by the type II PanK of S. aureus [18]. As P. 
falciparum is also predicted to express a type II PanK [20] and 
has previously been shown to phosphorylate other pantothe-
nate analogues [21,22], it seems likely that the observed inhi-
bition of pantothenate phosphorylation is a consequence of the 
analogues serving as PanK substrates. Should this be true, the 
antiplasmodial effect could in turn be a consequence of phos-
phopantothenate depletion and/or the phosphorylated en-
amides acting as inhibitors of PPCS (the subsequent enzyme 
in the CoA biosynthesis pathway), as has been shown to be the 
case in S. aureus [18]. An alternate possibility is that the CoA 
biosynthesis pathway metabolizes the phosphorylated en-
amides further to produce CoA anti-metabolites that in turn 
kill the parasite. Bacterial CoA biosynthesis enzymes have 
previously been shown to metabolize amide analogues of pan-
tothenate (pantothenamides) to yield CoA anti-metabolites 
[23]. The establishment of a reliable overexpression system 
for PfPanK will greatly facilitate further investigations into the 
mechanism of action of enamide and other analogues of panto-
thenate. Based on the observed relationship between the effect 
of the ester analogues of CJ-15,801 on pantothenate phos-
phorylation and their antiplasmodial effect, it is tempting to 
speculate that the interaction with PanK is a key determinant 
of antiplasmodial activity. The observation that CJ-15,801 
does not conform with the rest of the series, however, impli-
cates an additional/alternate determinant (such as uptake 
and/or affinity of the phosphorylation-activated compound for 
PPCS). For example, as CJ-15,801 most closely resembles 
pantothenate than the ester analogues, its activated deriva-
tive(s) may bind the ultimate target with higher affinity, com-
pensating for a lower rate of activation by PanK. Understand-
ing why CJ-15,801 behaves as an outlier has implications for 
elucidating the mechanism of action of these and possibly 
other pantothenate analogues. 
2.4 Susceptibility to esterase-mediated hydrolysis 
The SAR observed for the ester analogues of CJ-15,801 in 
the pantothenate phosphorylation assay suggests that the ester 
moieties are not readily hydrolysed under the conditions of 
this assay (Figure 4). However, to investigate whether R,E-1d
is subject to esterase-mediated hydrolysis within P. falcipa-
rum-infected erythrocytes, we synthesized R,E-1d (as well as 
CJ-15,801, for reference) with 13C labels introduced into the 
enamide moiety. The labeled compounds were synthesized 
using 13C2-bromoacetic acid (8) and 
13C-formic acid (12) as 
precursors (Schemes 3 and 4). P. falciparum-infected erythro-
cytes were incubated with 13C-R,E-1d and, after 3 h, metabo-
lites were extracted from the parasite. The extracts were then 
analyzed by 1H-13C-heteronuclear single quantum coherence 
(HSQC) NMR. Peaks corresponding to the olefinic carbons of 
R,E-1d, but not CJ-15,801, were observed (Figure 5), con-
sistent with intact R,E-1d gaining access to the parasite and 
the ester moiety primarily being retained. 
Scheme 3. Incorporation of 13C-labeled building blocks 
into synthetic intermediates. 
Reagents and conditions: (i) 2-(trimethylsilyl)ethanol, DCC, 
DMAP, DCM, 0 ˚C, 2 h, 68%; (ii) PPh3, toluene, RT, 18 h, 65%; 
(iii) neat, 50 ˚C, 3 h, 70%; (iv) benzotriazole, THF, -10 ˚C, 1 h, 
99%. 
2.5 1H NMR analysis of compound reactivity 
CJ-15,801 and analogues 1a-e share an Į,ȕ-unsaturated car-
bonyl moiety that could potentially act as a Michael acceptor, 
and, consequently, react non-specifically with proteins [24]. 
The observed antagonistic effect of pantothenate (Figure 2), 
SAR observed among CJ-15,801 analogues that retain the R-
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Scheme 4. Synthesis of 13C3-CJ-15,801 and 
13C3-R,E-1d. 
Reagents and conditions: (i) n-BuLi, THF, 0 ˚C, 0.5 h then 14, 
0 ˚C, 16 h, 78%; (ii) 10, NaOH / DCM, RT, 2 h then 13C3-R-2g, 
C6H6, 80 ˚C, 16 h, 97 %; (iii) TBAF, THF, 40 ˚C, 18 h, 80%; (iv) 
BiCl3, aq. MeCN, RT, 16 h, 41%; (v) BnOH, DCC, DMAP, 
DCM, 0 ˚C, 4 h, 41%. 
Figure 5. 1H-13C-HSQC analysis of metabolites extracted from 
parasites following a 3-h incubation of P. falciparum-infected 
erythrocytes with 13C3-R,E-1d. 1H-13C-HSQC spectra of (A) 
13C3-R,E-1d (1 mM), (B) 13C3-CJ-15,801 (1 mM), and extracts 
prepared from ~2 × 108 parasites after incubating P. falciparum-
infected erythrocytes (> 95% parasitemia) for 3 h with 13C3-R,E-
1d (C) or unlabeled R,E-1d (D) are shown. The spectra shown in 
C and D are representative of those obtained in two independent 
experiments. All spectra were acquired in D2O containing TSP (5 
mM for A and B, or 200 μM for C and D) as an internal 1H and 
13C chemical shift reference. The cross-peaks corresponding to the 
olefinic CH groups of 13C3-R,E-1d and 13C3-CJ-15,801 are circled 
in red and green, respectively.
pantoyl moiety (Table 1), and previous demonstration that 
after phosphorylation and cytidylylation CJ-15,801 acts as a  
tight-binding rather than irreversible inhibitor of S. aureus
PPCS, provide strong evidence that the observed inhibitory 
activities (on parasite growth and pantothenate phosphoryla-
tion) are a result of a specific effect and not a result of the 
compounds reacting non-specifically. Nevertheless, we used 
1H NMR to investigate directly the reactivity of CJ-15,801 and 
R,E-1d. We were unable to detect any reaction between these 
compounds and glutathione or L-cysteine following a 2 h in-
cubation at the pH (pH 7.4) used in the parasite growth and 
pantothenate phosphorylation assays (Supplementary infor-
mation Figure S2). By contrast, under the same conditions, N-
ethylmaleimide (a compound with a reactive Michael accep-
tor) reacted rapidly (before the first NMR spectrum was ac-
quired 15 min after mixing with the thiols). 
2.6 Selectivity 
The selectivity of CJ-15,801 and its analogues was further 
explored by screening the compounds against two human cell 
lines: an immortalized cell line, namely, the human embryonic 
kidney (HEK-293) cell line, and a low-passage cell line (i.e. 
with a finite lifetime), namely, the human Caucasian fetal lung 
fibroblast WI-38 cell line. The effect of the enamides on pro-
liferation of HEK-293 and WI-38 cells was assessed over 96 
h, or 48 h, respectively. Favorably, the enamides with a panto-
thenate-dependent antiplasmodial effect (i.e. CJ-15,801 and 
ester analogues R,E-1c-e) showed little-to-no effect on the 
proliferation of HEK-293 or WI-38 cells at a concentration of 
100 μM ( 5% and  36% inhibition, respectively) (Support-
ing information Table S1). The same was also true of the re-
maining pantoyl-bearing enamides tested. As the compounds 
did not inhibit proliferation of the cell lines by more than 50% 
at the highest concentration, we were unable to determine an 
absolute IC50 from which we could calculate absolute selec-
tivity indices. Therefore, we instead divided the highest con-
centration of the enamides tested against human cells (at 
which proliferation was inhibited by < 50%) by the IC50 meas-
ured against the parasite, to obtain a lower limit for the selec-
tivity index (Supporting information Table S1). The enamide 
with the greatest antiplasmodial effect (R,E-1d) was more than 
eight times more effective against the parasite. 
The low cytotoxicity observed for the key antiplasmodial 
compounds (R,E-1c-d) is encouraging and consistent with the 
compounds not being generally toxic, and rather inhibiting 
parasite proliferation via a specific mechanism. In the future, it 
will be important to investigate the basis for the observed se-
lectivity (e.g. by studying the effects on CoA biosynthesis in 
mammalian cells directly as done by Zhang et al. [25]) to en-
sure optimization only of molecules that also lack toxicity in 
vivo. 
3. Conclusions 
In conclusion, the R-pantoyl moiety and trans-substituted 
double bond geometry of CJ-15,801 was found to be critical 
for inhibition of pantothenate phosphorylation and an an-
tiplasmodial effect that can be antagonized by pantothenate. 
The pantothenate concentration-independent effect of en-
amides without these key structural features is consistent with 
these compounds primarily inhibiting parasite proliferation 
through an unknown mechanism(s) unrelated to inhibition of 
pantothenate and/or CoA utilization. Replacement of the car-
boxylic acid with esters was tolerated and even led to im-
proved inhibition of pantothenate phosphorylation and, for the 
most sterically-hindered ester analogue (R,E-1d), also led to 
increased antiplasmodial activity. These data suggest that fu-
ture medicinal chemistry efforts should focus on additional 
carboxylic acid replacements as a means to improve activity. 
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Second generation analogues with improved activity should 
be tested not only for activity against the disease-causing 
asexual blood stage of P. falciparum (as done in this study) 
but also for activity against the liver stage, and the stage infec-
tive to mosquitoes (gametocytes), to investigate their potential 
as prophylactic and transmission blocking drugs, respectively. 
As the CoA-dependent fatty acid synthesis pathway is required 
for survival of liver stage parasites [26,27], inhibitors of CoA 
biosynthesis (pending the ability to permeate liver cells) are 
anticipated to be active against liver stage parasites. Fletcher et 
al. [28] have identified compounds structurally distinct from 
pantothenate analogues that inhibit growth of P. falciparum
via an effect on CoA biosynthesis. Some of these molecules 
also inhibit early and late stage gametocytes, suggesting that 
other molecules that target CoA biosynthesis might also be 
effective against these forms of the parasite. 
Appendix A. Supplementary data 
Effect of enamides with a substituted double bond and/or pan-
toyl replacement on P. falciparum PanK-catalyzed pantothenate 
phosphorylation (Figure S1), 1H NMR analysis of enamide reac-
tivity (Figure S2), cytotoxicity of enamides against the human 
embryonic kidney (HEK-293) and human Caucasian fetal lung 
fibroblast (WI-38) cell lines (Table S1), experimental procedures, 
and 1H and 13C NMR spectra of the test compounds. 
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